Literature DB >> 22718938

Evolution of testing algorithms at a university hospital for detection of Clostridium difficile infections.

Karissa Culbreath1, Edward Ager, Ronald J Nemeyer, Alan Kerr, Peter H Gilligan.   

Abstract

We present the evolution of testing algorithms at our institution in which the C. Diff Quik Chek Complete immunochromatographic cartridge assay determines the presence of both glutamate dehydrogenase and Clostridium difficile toxins A and B as a primary screen for C. difficile infection and indeterminate results (glutamate dehydrogenase positive, toxin A and B negative) are confirmed by the GeneXpert C. difficile PCR assay. This two-step algorithm is a cost-effective method for highly sensitive detection of toxigenic C. difficile.

Entities:  

Mesh：

Substances：

Year:  2012        PMID： 22718938      PMCID： PMC3421798          DOI： 10.1128/JCM.00992-12

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN： 0095-1137            Impact factor:   5.948


  26 in total

1.  Effective detection of toxigenic Clostridium difficile by a two-step algorithm including tests for antigen and cytotoxin.

Authors:  John R Ticehurst; Deborah Z Aird; Lisa M Dam; Anita P Borek; John T Hargrove; Karen C Carroll
Journal:  J Clin Microbiol       Date:  2006-03       Impact factor: 5.948

2.  European Society of Clinical Microbiology and Infectious Diseases (ESCMID): treatment guidance document for Clostridium difficile infection (CDI).

Authors:  M P Bauer; E J Kuijper; J T van Dissel
Journal:  Clin Microbiol Infect       Date:  2009-12       Impact factor: 8.067

3.  Laboratory testing for Clostridium difficile infection: light at the end of the tunnel.

Authors:  Lance R Peterson; Maitry S Mehta; Parul A Patel; Donna M Hacek; Maureen Harazin; Payal P Nagwekar; Richard B Thomson; Ari Robicsek
Journal:  Am J Clin Pathol       Date:  2011-09       Impact factor: 2.493

4.  Reevaluation of the Premier Clostridium difficile toxin A and B immunoassay with comparison to glutamate dehydrogenase common antigen testing evaluating Bartels cytotoxin and Prodesse ProGastro Cd polymerase chain reaction as confirmatory procedures.

Authors:  Kirk M Doing; Marilyn S Hintz; Calvin Keefe; Sarah Horne; Shelby LeVasseur; Martha L Kulikowski
Journal:  Diagn Microbiol Infect Dis       Date:  2010-02       Impact factor: 2.803

5.  The search for a better treatment for recurrent Clostridium difficile disease: use of high-dose vancomycin combined with Saccharomyces boulardii.

Authors:  C M Surawicz; L V McFarland; R N Greenberg; M Rubin; R Fekety; M E Mulligan; R J Garcia; S Brandmarker; K Bowen; D Borjal; G W Elmer
Journal:  Clin Infect Dis       Date:  2000-10-25       Impact factor: 9.079

6.  Comparison of nine commercially available Clostridium difficile toxin detection assays, a real-time PCR assay for C. difficile tcdB, and a glutamate dehydrogenase detection assay to cytotoxin testing and cytotoxigenic culture methods.

Authors:  Kerrie Eastwood; Patrick Else; André Charlett; Mark Wilcox
Journal:  J Clin Microbiol       Date:  2009-08-26       Impact factor: 5.948

7.  Evaluation of tcdB real-time PCR in a three-step diagnostic algorithm for detection of toxigenic Clostridium difficile.

Authors:  Ann M Larson; Angela M Fung; Ferric C Fang
Journal:  J Clin Microbiol       Date:  2009-11-18       Impact factor: 5.948

8.  Comparison of BD GeneOhm Cdiff real-time PCR assay with a two-step algorithm and a toxin A/B enzyme-linked immunosorbent assay for diagnosis of toxigenic Clostridium difficile infection.

Authors:  Elizabeth J Kvach; David Ferguson; Paul F Riska; Marie L Landry
Journal:  J Clin Microbiol       Date:  2009-10-28       Impact factor: 5.948

9.  Rapid and reliable diagnostic algorithm for detection of Clostridium difficile.

Authors:  Lukas Fenner; Andreas F Widmer; Gisela Goy; Sonja Rudin; Reno Frei
Journal:  J Clin Microbiol       Date:  2007-11-21       Impact factor: 5.948

10.  Is a two-step glutamate dehyrogenase antigen-cytotoxicity neutralization assay algorithm superior to the premier toxin A and B enzyme immunoassay for laboratory detection of Clostridium difficile?

Authors:  Peter H Gilligan
Journal:  J Clin Microbiol       Date:  2008-02-06       Impact factor: 5.948
View more
  18 in total

Review 1.  Laboratory diagnosis of bacterial gastroenteritis.

Authors:  Romney M Humphries; Andrea J Linscott
Journal:  Clin Microbiol Rev       Date:  2015-01       Impact factor: 26.132

2.  Evaluation of a new automated homogeneous PCR assay, GenomEra C. difficile, for rapid detection of Toxigenic Clostridium difficile in fecal specimens.

Authors:  Jari J Hirvonen; Silja Mentula; Suvi-Sirkku Kaukoranta
Journal:  J Clin Microbiol       Date:  2013-06-26       Impact factor: 5.948

3.  Rapid, label-free genetic detection of enteropathogens in stool without genetic isolation or amplification.

Authors:  Song Han; Mehmet C Soylu; Ceyhun E Kirimli; Wei Wu; Bhaswati Sen; Suresh G Joshi; Christopher L Emery; Giang Au; Xiaomin Niu; Richard Hamilton; Kyle Krevolin; Wei-Heng Shih; Wan Y Shih
Journal:  Biosens Bioelectron       Date:  2019-01-21       Impact factor: 10.618

Review 4.  Laboratory Tests for the Diagnosis of Clostridium difficile.

Authors:  Karen C Carroll; Masako Mizusawa
Journal:  Clin Colon Rectal Surg       Date:  2020-02-25

Review 5.  Diagnosis of Clostridium difficile infection: an ongoing conundrum for clinicians and for clinical laboratories.

Authors:  Carey-Ann D Burnham; Karen C Carroll
Journal:  Clin Microbiol Rev       Date:  2013-07       Impact factor: 26.132

6.  Laboratory diagnosis of Clostridium difficile infection: Comparison of Techlab C. diff Quik Chek Complete, Xpert C. difficile, and multistep algorithmic approach.

Authors:  Ja Young Seo; Ji Hun Jeong; Kyung Hee Kim; Jeong-Yeal Ahn; Pil-Whan Park; Yiel-Hea Seo
Journal:  J Clin Lab Anal       Date:  2017-02-08       Impact factor: 2.352

7.  Comparison of BD Max Cdiff and GenomEra C. difficile molecular assays for detection of toxigenic Clostridium difficile from stools in conventional sample containers and in FecalSwabs.

Authors:  J J Hirvonen; S-S Kaukoranta
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2015-01-24       Impact factor: 3.267

8.  Alerting physicians during electronic order entry effectively reduces unnecessary repeat PCR testing for Clostridium difficile.

Authors:  Robert F Luo; Suzanne Spradley; Niaz Banaei
Journal:  J Clin Microbiol       Date:  2013-08-28       Impact factor: 5.948

9.  Economic evaluation of laboratory testing strategies for hospital-associated Clostridium difficile infection.

Authors:  Lee F Schroeder; Elizabeth Robilotti; Lance R Peterson; Niaz Banaei; David W Dowdy
Journal:  J Clin Microbiol       Date:  2013-11-27       Impact factor: 5.948

10.  Preventable Patient Harm: a Multidisciplinary, Bundled Approach to Reducing Clostridium difficile Infections While Using a Glutamate Dehydrogenase/Toxin Immunochromatographic Assay/Nucleic Acid Amplification Test Diagnostic Algorithm.

Authors:  Katherine Schultz; Emily Sickbert-Bennett; Ashley Marx; David J Weber; Lauren M DiBiase; Stacy Campbell-Bright; Lauren E Bode; Mike Baker; Tom Belhorn; Mark Buchanan; Sherie Goldbach; Jacci Harden; Emily Hoke; Beth Huenniger; Jonathan J Juliano; Michael Langston; Heather Ritchie; William A Rutala; Jason Smith; Shelley Summerlin-Long; Lisa Teal; Peter Gilligan
Journal:  J Clin Microbiol       Date:  2018-08-27       Impact factor: 5.948
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.